Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) EPS (Basic) (2017 - 2025)

Catheter Precision has reported EPS (Basic) over the past 9 years, most recently at -$2.88 for Q4 2025.

  • Quarterly EPS (Basic) fell 105.83% to -$2.88 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.32 through Dec 2025, down 363.37% year-over-year, with the annual reading at -$15.9 for FY2025, 87.47% up from the prior year.
  • EPS (Basic) was -$2.88 for Q4 2025 at Catheter Precision, down from -$1.7 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $49.36 in Q4 2024 and troughed at -$38.17 in Q3 2024.
  • The 5-year median for EPS (Basic) is -$2.66 (2021), against an average of -$5.63.
  • Year-over-year, EPS (Basic) plummeted 24109.22% in 2023 and then skyrocketed 8247.11% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$37.4 in 2021, then surged by 105.4% to $2.02 in 2022, then plummeted by 129.99% to -$0.61 in 2023, then skyrocketed by 8247.11% to $49.36 in 2024, then plummeted by 105.83% to -$2.88 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EPS (Basic) are -$2.88 (Q4 2025), -$1.7 (Q3 2025), and -$0.38 (Q2 2025).